Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

China · Delayed Price · Currency is CNY

43.22

+3.93 (10.00%)

Jul 10, 2026, 3:00 PM CST

62.97% (1Y)

Market Cap	28.97B +107.2%
Revenue (ttm)	1.69B -14.9%
Net Income	495.08M +27.8%
EPS	0.68 +33.4%
Shares Out	733.37M
PE Ratio	63.31
Forward PE	71.59
Dividend	0.12 (0.31%)
Ex-Dividend Date	Jun 30, 2026

Volume	53,574,855
Open	38.65
Previous Close	39.29
Day's Range	38.64 - 43.22
52-Week Range	24.44 - 45.95
Beta	0.80
Analysts	Buy
Price Target	33.26 (-23.04%)
Earnings Date	Aug 29, 2026

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization s... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1995

Employees 2,649

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603127

Full Company Profile

Financial Performance

In 2025, SHA:603127's revenue was 1.66 billion, a decrease of -17.87% compared to the previous year's 2.02 billion. Earnings were 297.84 million, an increase of 302.08%.

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for 603127 stock is "Buy." The 12-month stock price target is ¥33.26, which is a decrease of -23.04% from the latest price.

Price Target

¥33.26

(-23.04% downside)

Analyst Consensus: Buy

Stock Forecasts